Drawing for KAZIA

USPTO serial 79226824

KAZIA

Reviewed by CopyMark Law Group

Reg. 5619703Status 706Registered
Filing date
Status date
Registration date
Dec 4, 2018
Examiner
FLETCHER, TRACY L
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with KAZIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sana Hakim

Sana Hakim K&L Gates LLPP.O. Box 1135Chicago, IL 60690-1135United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in science; chemicals for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticalsACTIVE—
005Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposesACTIVE—
042Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 9, 202571AGREGISTERED-SEC.71 ACCEPTED—
Sep 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 3, 2025ES71TEAS SECTION 71 RECEIVED—
Dec 4, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 19, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 29, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 15, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 11, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 11, 2019FIMPFINAL DISPOSITION PROCESSED—
Mar 4, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 4, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 18, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2018GPNXNOTIFICATION PROCESSED BY IB—
Aug 29, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 29, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 29, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 16, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 16, 2018DMCCDATA MODIFICATION COMPLETED—
Aug 14, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Aug 14, 2018ALIEASSIGNED TO LIE—
Aug 14, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 14, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 14, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 6, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 24, 2018RFNTREFUSAL PROCESSED BY IB—
Mar 7, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 7, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 2, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 1, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 28, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2018DOCKASSIGNED TO EXAMINER—
Feb 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance